Allhat trial clearance
Allhat trial clearance
Allhat trial clearance
Allhat trial clearance
Allhat trial clearance
Allhat trial clearance

Allhat trial clearance

Allhat trial clearance, PDF Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs. diuretic. the Antihypertensive and Lipid Lowering Treatment t... clearance

$49.00

SKU: 6971219

Colour
  • Diuretics in CKD PPT
  • Allhat Trial Summary 2024 www.levitan
  • Heterogeneity in Early Responses in ALLHAT Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial Hypertension
  • Frontiers The 18 year risk of cancer angioedema insomnia depression and erectile dysfunction in association with antihypertensive drugs post trial analyses from ALLHAT Medicare linked data
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus